Indiana University (Site 400) — Indianapolis, Indiana

Indiana University (Site 400) is a clinical research site located in Indianapolis, Indiana, United States 46202.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Indiana University (Site 400) has participated in 1 clinical trials.

Therapeutic areas: Neurofibromatosis 2, Progressive Vestibular Schwannoma (VS).

Sponsors: University of Alabama at Birmingham.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Indiana University (Site 400)?

Indiana University (Site 400) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Indiana University (Site 400) conducted?

Indiana University (Site 400) has 1 clinical trials on record. Their work covers Neurofibromatosis 2, Progressive Vestibular Schwannoma (VS).

Is Indiana University (Site 400) accredited by Crixeo Health?

Indiana University (Site 400) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Indiana University (Site 400)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.